Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

SUMMARY: BACKGROUND: The optimal dose of grass pollen tablets for sublingual immunotherapy (SLIT) in allergic rhinoconjunctivitis patients was previously established in a multinational, randomized, double-blind, placebo-controlled study in 628 adults. Patients were randomized to receive once-daily 5...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Exp Allergy
Hlavní autoři: Malling, H-J, Montagut, A, Melac, M, Patriarca, G, Panzner, P, Seberova, E, Didier, A
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2009
Témata:
Original Articles: Editor's Choice: Clinical Allergy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4233960/
https://ncbi.nlm.nih.gov/pubmed/19134019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2222.2008.03152.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky